Indefinite Delivery Contract SPE2DR25D1257

Award Date 8/1/25
Last Date to Order 12/31/36
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The Indefinite Delivery Contract (IDC) SPE2DR25D6035 was awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $999,999,999, is a single-award IDC with a period of performance through December 31, 2036. The purpose of this IDC is to establish a Pharmaceutical Prime Vendor Global Program to provide worldwide pharmaceutical support, including...
This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $999,999,999, has a base period of 30 months and three 30-month option periods, running through December 2036. The purpose of this IDC is to establish Pharmaceutical Prime Vendor contracts to provide worldwide pharmaceutical support to various...
This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $999,999,999, has a 30-month base period and three 30-month option periods, running through December 2036. The purpose of this IDC is to establish a Pharmaceutical Prime Vendor Global Program to provide worldwide pharmaceutical support, including...
This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $999,999,999 IDC, with a period of performance through December 2036, serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract aims to...
This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $999,999,999, is for the provision of a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical commodities including specialty medications,...
This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $999,999,999, provides worldwide pharmaceutical support to various Department of Defense (DoD) customers, including the Defense Health Agency, DoD entities, the U.S. Coast Guard, and the U.S. Naval Fleet, through the Pharmaceutical Prime Vendor...
The Indefinite Delivery Contract (IDC) SPE2DR25D7910 was awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $999,999,999, has a period of performance through December 2026 and is intended to provide worldwide pharmaceutical support to various Department of Defense (DoD) customers, including the Defense Health Agency, the U.S. Coast Guard, and...
The Indefinite Delivery Contract (IDC) SPE2DR25D7005 was awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for a ceiling value of $999,999,999.00. The contract, which runs through December 2036, provides worldwide pharmaceutical support to various DoD customers, including the Defense Health Agency, Department of Defense, United States Coast Guard, and US Naval Fleet. Amerisourcebergen will be...
This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $999,999,999, has a 30-month base period with three 30-month option periods, and runs through December 2036. The contract aims to establish Pharmaceutical Prime Vendor Global Program Generation V contracts to provide worldwide pharmaceutical support...
This Indefinite Delivery Contract (IDC) award, valued at $999,999,999, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The IDC encompasses a broad spectrum of critical medical commodities including...

This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $999,999,999, has a period of performance through December 2036 and aims to establish Pharmaceutical Prime Vendor Global Program Generation V contracts to provide worldwide pharmaceutical support to various DoD customers, including the Defense Health Agency, Department of Defense, United States Coast Guard, and U.S. Naval Fleet.

The contracted products and services encompass a comprehensive range of pharmaceutical and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. The IDC serves as a primary vehicle for DLA to efficiently procure these essential medical commodities to support the healthcare needs of military personnel, veterans, and other federal beneficiaries. This unrestricted, competitively awarded contract does not utilize any set-asides and allows for multiple primary supplier awards across different geographic regions to enhance the Department of Defense's resiliency and access to vital pharmaceuticals.

Generated 6/6/25, 9:55 AM